Rheumnow Podcast
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Latest episodes
Nov 11, 2022 • 30min
QD Clinics - ACR 2022
QD201 - Seropositive Arthralgia (abstract #1604) https://youtu.be/uQt_IV3FmZc
QD202 -1st Line Anakinra (abstract #L12) https://youtu.be/QyDVQBnYqn4
QD203 - When to Worry About Malignancy and Myositis (abstract #002) https://youtu.be/qt-debWfSrY
QD204 How to Treat Erosive OA (abstract #L05) https://youtu.be/5-atRyBsCn4
QD205 - RA Activity During Pregnancy (abstract #0955) https://youtu.be/wavTWqZbhq4
Nov 4, 2022 • 19min
Women with Rheumatic Disease (11.4.2022)
Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com. New regulatory decisions about JAK inhibitors and why do women with rheumatic diseases have unfair outcomes?
Nov 1, 2022 • 9min
Dr Nimesh Dayal on the Use of axSpA Endpoints in Clinical Practice Sponsored by AbbVie Medical Affairs
Dr. Nimesh Dayal (Orlando Health-Health Central Hospital, Orlando, FL) discusses the relevance of clinical endpoints and guidelines for ax-SpA in clinical practice.
Oct 28, 2022 • 20min
Infections & Lupus (10.28.2022)
Dr. Jack Cush discussess the news and journal reports from the past week on RheumNow.com . This week more lupus nephritis, more drug induced lupus and more lupus infections that may kill.
Oct 21, 2022 • 21min
ACR Award Winners (10.21.2022)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Highlighted discussion of implantable stimulators, urine proteomics and gut-immune responses to Prevotella in RA.
Oct 14, 2022 • 33min
AOSD - Adult-onset Still’s disease
Review of Adult-onset Still's Disease by Dr. Jack Cush, Executive Editor of RheumNow.com
Oct 14, 2022 • 20min
Primer on Clinical Trials (10.14.2022)
Dr. Jack Cush reviews:
- Should you do clinical trials?
- how to start in clinical trials
- Types of studies
- Benefits to research
Oct 7, 2022 • 19min
Thats Not My Name (10.7.2022)
Dr. Jack Cush goes off on "Untitling" (not using proper names/titles) in the clinic, in additon to reports on rheumatologist salaries, new drugs in phase 1-3 development and the range of COVID-19 MSK symptoms -- all from the past week on RheumNow.com.
Sep 30, 2022 • 24min
Perspectives on the safety of a JAK inhibitor in RA, PsA, and AS – Featuring Drs Wickersham, Winthrop, and Ritchlin Sponsored by AbbVie Medical Affairs
Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.
Sep 30, 2022 • 22min
Great and Not-So Great (9.30.2022)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.
